Abstract
The pivotal role of Ras as a transducer of vital signals is well established. As such, aberrant Ras signaling is associated with cancer, neurofibromatosis, and Alzheimer's disease. This realization could make detection of mutated ras a useful diagnostic and prognostic tool. Exploiting the biochemical properties of Ras has made interfering with Ras activity a potential clinical option and dissection of the relative contribution of each signaling pathway emanating from Ras will certainly provide additional targets for clinical intervention. © 1996 Elsevier Inc. All rights reserved.
| Original language | American English |
|---|---|
| Journal | Advances in Oncobiology |
| Volume | 1 |
| DOIs | |
| State | Published - Dec 1 1996 |
| Externally published | Yes |
Disciplines
- Biology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS